Kolexia
Seitz Jean-Francois
Gastro-entérologie
Hôpital La Timone
Marseille, France
230 Activités
39 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Carcinomes Tumeurs du côlon Tumeurs du pancréas Métastase tumorale Tumeurs du foie Carcinome hépatocellulaire Tumeurs du rectum

Industries

Pierre Fabre
3 collaboration(s)
Dernière en 2020
Oséus
1 collaboration(s)
Dernière en 2021
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Suite : Intervention du Professeur Jean-Francois SEITZ, Professeur ...
Facebook   01 décembre 2023
Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   25 août 2023
DECODE: Impact of Health Literacy Training for General Practitioners and a Consumer Facing Intervention to Improve Colorectal Cancer Screening in Underserved Areas: A Multicentric Cluster Randomized Controlled Trial
Essai Clinique (Université Paul Sabatier Toulouse III)   02 mai 2023
🔵 #MarsBleu - Le dépistage du cancer colorectal
Youtube @ Bayer France   31 mars 2023
Comment éviter le cancer colorectal? Avec le professeur Jean-François Seitz
Youtube @ MProvence TV   01 mars 2023
Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD).
BMC cancer   05 janvier 2023
Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial.
Therapeutic advances in medical oncology   26 décembre 2022
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database.
Journal of the National Cancer Institute   21 novembre 2022
PANOPTIMOX: Randomised Phase II Study in Metastatic Pancreatic Cancer Evaluating FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem in First-line
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   18 août 2022
Colorectal cancer screening by fecal immunochemical test or colonoscopy in France: how many people are actually covered? Focus on the Provence-Alpes-Côte d'Azur region.
European journal of gastroenterology & hepatology   14 avril 2022